Discrepancies in assignment of subtype/recombinant forms by genotyping programs for HIV type 1 drug resistance testing may falsely predict superinfection

AIDS Research and Human Retroviruses

Volumn 24, Issue 7, 2008, Pages 995-1002

  Ntemgwa, Michel ^a,b   Gill, M John ^c   Brenner, Bluma G ^a   Moisi, Daniela ^a   Wainberg, Mark A ^a,b,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANTIVIRAL RESISTANCE; ARTICLE; DRUG SENSITIVITY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; ONLINE ANALYSIS; PHYLOGENETIC TREE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUPERINFECTION; VIRUS INFECTION; VIRUS RECOMBINANT;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; FALSE POSITIVE REACTIONS; HIV INFECTIONS; HIV-1; HUMANS; MALE; SEQUENCE ANALYSIS; SUPERINFECTION; VARIATION (GENETICS);

EID: 48749133585     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0064     Document Type: Article

References (16)

1. Gifford R, de Oliveira T, Rambaut A, et al.: Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity. AIDS 2006;20:1521-1529.
2. Kozaczynska K, Cornelissen M, Reiss P, Zorgdrager F, and van der Kuyl AC: HIV-1 sequence evolution in vivo after superinfection with three viral strains. Retrovirology 2007;4:59.
3. Pernas M, Casado C, Fuentes R, Perez-Elias MJ, and Lopez-Galindez C: A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J Acquir Immune Defic Syndr 2006;42:12-18.
4. Turner D, Brenner B, Moisi D, et al.: Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1. Antimicrob Agents Chemother 2004;48:2993-2998.
5. Turner D, Brenner B, Mosis D, Liang C, and Wainberg MA: Substitutions in the reverse transcriptase and protease genes of HIV-1 subtype B in untreated individuals and patients treated with antiretroviral drugs. MedGenMed 2005;7:69.
6. Brenner BG, Roger M, Routy JP, et al.: High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007;195:951-959.
7. Pasquier C, Millot N, Njouom R, et al.: HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001;94:45-54.
8. Yahi N, Fantini J, Tourres C, Tivoli N, Koch N, and Tamalet C: Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. J Infect Dis 2001;183:1311-1317.
9. Akouamba BS, Viel J, Charest H, et al.: HIV-1 genetic diversity in antenatal cohort, Canada. Emerg Infect Dis 2005;11:1230-1234.
10. Zhang M, Schultz AK, Calef C, et al.: jpHMM at GOBICS: A web server to detect genomic recombinations in HIV-1. Nucleic Acids Res 2006;34:W463-465.
11. Abecasis AB, Deforche K, Snoeck J, et al.: Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G. AIDS 2005;19:1799-1806.
12. Kumar S, Tamura K, and Nei M: MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;5:150-163.
13. Ntemgwa M, Toni T, Brenner BG, Routy J-P, Moisi D, Oliveira M, and Wainberg MA: Near full-length genomic analysis of a novel subtype A1/C recombinant HIV-1 isolate from Canada. AIDS Res Hum Retroviruses 2008;24:655-659.
14. Brenner B, Turner D, Oliveira M, et al.: A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers crossresistance to non-nucleoside reverse transcriptase inhibitors. AIDS 2003;17:F1-5.
15. Brenner BG, Oliveira M, Doualla-Bell F, et al.: HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. AIDS 2006;20:F9-13.
16. Doualla-Bell F, Avalos A, Brenner B, et al.: High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Antimicrob Agents Chemother 2006;50:4182-4185.